Amgen Discontinues Development of MGDF.THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. , Calif.--(BUSINESS WIRE)--Sept. 11, 1998--Amgen (Nasdaq:AMGN) Friday reported that it has discontinued development of its megakaryocyte megakaryocyte /mega·karyo·cyte/ (-sit?) the giant cell of bone marrow containing a greatly lobulated nucleus, from which mature blood platelets originate.megakaryocyt´ic meg·a·kar·y·o·cyte n. growth and development factor (PEG-rHuMGDF) due to evidence of neutralizing antibodies neu·tral·iz·ing antibody n. An antibody that reacts with an infectious agent, usually a virus, and destroys or inhibits its infectiveness and virulence. in a few patients participating in cancer clinical trials and in additional people in platelet donor clinical trials. Amgen is a global biotechnology company that discovers, develops, manufactures and markets cost-effective human therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. based on advances in cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller . EDITOR S NOTE: An electronic version of this news release may be accessed via our Web site at www.Amgen.com. Visit the Corporate Center and click on Amgen News. Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Amgen News section of the Web site.
CONTACT: Amgen, Thousand Oaks
David Kaye, 805/447-6692 (media)
Denise Powell, 805/447-4346 (investors)
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion